Application 219239
- Type
- ANDA
- Sponsor
- GLAND
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPINEPHRINE | EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 10MG/10ML (1MG/ML) | No | No |
| 002 | EPINEPHRINE | EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 30MG/30ML (1MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219239-001 | EPINEPHRINE | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | |
| A219239-002 | EPINEPHRINE | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | |
| A219239-003 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2026-09-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219239-001 | AP |
| A219239-002 | AP |
| A219239-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219239-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2026-09-22 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219239-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2026-09-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAOCULAR, SUBCUTANEOUS | AP | 2025-02-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAOCULAR, SUBCUTANEOUS | AP | 2025-02-06 | b8a1b40f171c… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219239-001 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-02-06 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219239-002 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | 2025-10-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219239-001 | AP | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219239-002 | AP | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219239-003 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A219239-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219239-002 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219239-003 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A219239-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219239-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219239-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219239-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219239-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219239-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219239-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219239-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219239-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A219239-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A219239-001 | AP | 1 | b8a1b40f171c… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219239-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219239-002 | AP | 1 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219239-001 | CGT | 2025-09-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219239-001 | CGT | 2025-09-03 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| epinephrine | EPINEPHRINE | Sportpharm LLC | e7798493-9407-4a5d-9c90-0cc336c59ec1 | 2026-02-03 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | REMEDYREPACK INC. | de4916c5-bdc8-4da9-a857-a319882a831a | 2026-02-03 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Henry Schein, Inc. | af10f2bb-b0ad-45a6-b525-e715613350af | 2026-01-13 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| Adrenalin Vials | EPINEPHRINE | Sina Health Inc | 28649937-8ae1-a022-e063-6394a90aebe0 | 2026-01-12 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine 1553 | EPINEPHRINE | Professional Complementary Health Formulas | c06d262b-b97e-4921-b927-c51e1b27691e | 2026-01-08 | Warnings | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | 7499cbca-b8fe-4fc3-a318-13859ab989a7 | 2025-12-26 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | 3fd8dd51-0aeb-43dd-9de0-c11b0330b15e | 2025-12-26 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | db18519b-82a9-435b-85c7-a040d644f057 | 2025-12-26 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| Epinephrine | EPINEPHRINE | BPI Labs, LLC | 5b5282a9-b149-4f0a-978e-5adbf48ec8aa | 2025-12-26 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | ProPharma Distribution | 384445ac-0696-e367-e063-6394a90a019f | 2025-12-18 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| Adrenalin | EPINEPHRINE | ProPharma Distribution | 3eef2920-0129-6dc2-e063-6294a90ac22a | 2025-12-18 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | GLENMARK PHARMACEUTICALS INC., USA | 01fd19cd-190c-4989-b733-60ba95941297 | 2025-12-18 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| epinephrine | EPINEPHRINE | A-S Medication Solutions | a5134e63-9a31-4573-826f-b442d069b3e6 | 2025-11-19 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | ab5e23d0-6e99-4647-838d-23a4040602b5 | 2025-11-10 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| epinephrine | EPINEPHRINE | Amneal Pharmaceuticals LLC | c0ef05d5-3fc8-4fb4-bf5b-c219ff17b092 | 2025-10-31 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Medical Purchasing Solutions, LLC. | 409581e7-ab70-41f3-e063-6294a90a15dc | 2025-10-07 | Warnings, Adverse reactions | EPINEPHRINE EPINEPHRINE |
| Auvi-Q | EPINEPHRINE | kaleo, Inc | 6180fb40-7fca-4602-b3da-ce62b8cd2470 | 2025-10-02 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | ASCLEMED USA INC. | 76f65a94-4b26-4c40-8a74-79a73afbb4e2 | 2025-09-04 | Warnings, Adverse reactions | epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Redpharm Drug | 300ac735-4493-c02a-e063-6294a90a5bce | 2025-08-30 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
| Epinephrine | EPINEPHRINE | ProPharma Distribution | 3d728e53-92c2-114e-e063-6394a90ad404 | 2025-08-28 | Warnings, Adverse reactions | Epinephrine EPINEPHRINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81472 | ORIG | 2025-03-06 |